JUMPCODE GENOMICS INC.

In News

Jumpcode Genomics and TGen collaborate on genomic sequencing of SARS-CoV-2 - News-Medical

News-Medical - Sep 14, 2021

A Universal Day Zero Infectious Disease Testing Strategy Leveraging CRISPR-based Sample Depletion and Metagenomic Sequencing - medRxiv

medRxiv - May 16, 2022

CRISPR-Cas9 Technology Cuts Clutter from Sequencing Libraries - GEN - Genetic Engineering and Biotechnology News

GEN - Genetic Engineering and Biotechnology News - Sep 01, 2021

Ginkgo Technology Network Launches, Providing an Integrated R&D Experience with Capabilities from Over 25 Inaugural Partners - PR Newswire

PR Newswire - Feb 28, 2024

Element Biosciences unveils Aviti benchtop sequencing system - Fierce Biotech

Fierce Biotech - Mar 15, 2022

ERS Genomics and Dyadic Applied BioSolutions Sign CRISPR/Cas9 License Agreement - PR Newswire

PR Newswire - Nov 10, 2025

Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care - PR Newswire

PR Newswire - Feb 20, 2025

ERS Genomics & AlgenScribe Enter Into CRISPR/Cas9 Licensing Agreement - PR Newswire

PR Newswire - Sep 05, 2023

ERS Genomics & Santa Cruz Biotechnology Enter Into CRISPR/Cas9 Licensing Agreement - PR Newswire

PR Newswire - Aug 10, 2023

CRISPR/Cas9 license agreement for ERS Genomics and CIEA - PR Newswire

PR Newswire - Apr 07, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment